Creyos

🧠 Dementia care is outgrowing specialist capacity. The patients who stand to gain most from early intervention are often the ones waiting longest in the referral queue.

Some health systems have started moving objective cognitive assessment into primary care instead.

Our new white paper looks at how that redesign works in practice, including how one multi-state network rebuilt its cognitive screening program.

Download the white paper: https://hubs.li/Q04sgRgG0

🧠 ADHD referrals keep climbing, and the diagnosis still rests largely on self-report from interviews, developmental history, and rating scales.

Objective testing can add a measurable layer, but different tools measure different things. Motion tracking captures observable movement. Cognitive assessment profiles working memory, executive function, and inhibition.

Our latest article covers what the evidence supports for each, and where objective data fits in an ADHD evaluation.

Read more: https://hubs.li/Q04rZfjL0

💬 The clinical interview is the foundation of psychiatric assessment, and psychiatrist Dr. Rebecca Reyes has spent over 20 years refining hers.

But what the interview was never designed to do is measure.

Subtle shifts in attention, memory, and executive function can sit below what a conversation will surface, even with a patient the clinician knows well.

In our latest article, she maps where objective cognitive measurement fits alongside the interview, and shares two cases where the data changed her decision.

Read more: https://hubs.li/Q04r80HR0

🧠 55% of primary care physicians say their communities do not have enough dementia care specialists.

When a screen comes back abnormal, the next step can feel like it belongs somewhere else. Meanwhile medications go unreviewed, safety risks evolve, and the family keeps making daily decisions alone.

Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, wrote a new article on what primary care can do in the first 30 days after an abnormal cognitive screen.

Read more: https://hubs.ly/Q04qBK9P0

🕔 In a full-risk model, clinician time is one of the scarcest resources.

One full-risk Medicare Advantage organization moved its cognitive screening to a digital assessment that runs in about 6 minutes. Across a typical caseload, that returned roughly 1.5 hours per clinician per day to patient-facing care.

💻 In this on-demand webinar, Claremedica Chief Medical Officer Dr. Nehal Gheewala and SVP of Strategy & Analytics Benjamin Todd, joined by Creyos Chief Marketing Officer Erin Smith, discuss how they rebuilt detection within a full-risk model.

Watch the recording:
https://hubs.li/Q04prMMg0

👉 More than half of people with dementia are never formally evaluated for cognition during the early stages of the disease.

In a validation study published in the Journal of Alzheimer's Disease, the Creyos Screener detected Alzheimer's-related cognitive impairment with 100% sensitivity in about 6 minutes, with no clinical supervision required.

📄 Our full breakdown of the study: https://hubs.li/Q04pk8dY0

🧠 We're live at the Alzheimer's Association International Conference (AAIC) 2026 in London!

Creyos is excited to be onsite this week, with Sydni Paleczny meeting with researchers and clinical leaders from around the world to discuss the future of brain health, cognitive assessment, and dementia research.

It's already been a fantastic start to the conference, with insightful conversations, new connections, and exciting discussions around advancing cognitive care and research.

If you're at AAIC this week, we'd love to connect.

🔬 Advancing the conversation around earlier cognitive evaluation.

We're looking forward to joining researchers, clinicians, and partners at next week in London.

This year, research featuring Creyos digital cognitive assessment will be presented across two scientific posters:

• R-FIRE (Rural Firefighter Investigation of Risk & Exposure): Brain Health (Part of the Prospective Imaging Study of Aging (PISA))
Presented by Michelle Lupton, QIMR Berghofer

• Early Digital Cognitive Screening for Individuals Across the Dementia Continuum
Presented by Emily Moore, The Owen Lab at Western University

If you'll be at AAIC, we'd love to connect. Sydni Paleczny will be on site listening, learning and chatting with experts in the Alzheimer's space.

We're proud to share that Creyos has been named one of the 2026 Best Workplaces in Technology in Canada.

⭐ 98% of employees at Creyos say it's a great place to work.
⭐ 100% say Creyos is somewhere they can be themselves and have what they need to do their work well.

Thank you to everyone at Creyos who contributes to making this true.

See the full profile: https://hubs.li/Q04nXW5q0

📄 Mental health assessment relies in part on questionnaires like the PHQ-9, the GAD-7, and the PCL-5.

Each captures subjective symptoms across specific stages of care: screening, diagnosis, and symptom monitoring.

Objective cognitive data adds a second source of evidence, one that can corroborate a patient's self-report and add further detail to it.

Our latest article organizes the standard tools by condition, and shows where objective measurement fits alongside them.

Read more: https://hubs.li/Q04n4F6D0